(Q40047541)

16 September 2017

1 reference

title

The pharmacology of imipramine and related antidepressants (English)

1 reference

16 September 2017

The Pharmacology of Imipramine and Related Antidepressants (English)

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

1 reference

L. Gyermek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5337729

4 May 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5337729

4 May 2023

publication date

1 January 1966

1 reference

International Review of Neurobiology

16 September 2017

published in

1 reference

16 September 2017

volume

9

1 reference

16 September 2017

page(s)

95-143

1 reference

Biochemical studies on Tofranil

16 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

A SIMPLE SCREENING PROCEDURE FOR IMIPRAMINE-LIKE ANTIDEPRESSANT AGENTS

4 May 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Conversion of transquilizers to antidepressants by removal of one N-methyl group

4 May 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Effects of morphine and Tofranil on the incorporation of phosphate (32P) into phospolipids of rat brain slices.

4 May 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

11

2

70

Carlton

1960

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Interactions between reserpine, chlorpromazine, and imipramine

4 May 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Bollettino della Societa italiana di biologia sperimentale

4 May 2023

16

37

180

Crepax

1961

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Bollettino della Societa italiana di biologia sperimentale

4 May 2023

17

37

378

Crepax

1981

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

PSYCHOPHARMACOLOGY OF IMIPRAMINE AND DESIPRAMINE: A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES

4 May 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

DRUGS FOR DEPRESSION

24

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

ANTIDEPRESSANTS. II. DERIVATIVES OF POLYNUCLEAR INDOLES

4 May 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

The effect of imipramine and desmethylimipramine on lipid bio-synthesis in brain and liver.

4 May 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Effect of imipramine, amitriptyline and their monomethyl derivatives on reserpine activity

4 May 2023

31

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Isolation from rat brain of a metabolic product, desmethylimipramine, that mediates the antidepressant activity of imipramine (Tofranil).

4 May 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

41

6

179

Hanson

1964

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

IMIPRAMINE AND "DRINAMYL" IN DEPRESSIVE ILLNESS: A COMPARATIVE TRIAL.

4 May 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

46

3

75

Hill

1961

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Effect of the combined administration of imipramine and a monoamine oxidase inhibitor.

4 May 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

EVALUATION OF DESIPRAMINE IN DEPRESSIVE STATES

4 May 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Delayed audiofeedback (DAF) for induction of anxiety. Effect of nortriptyline, ethanol, or nortriptyline-ethanol combinations on performance with DAF.

4 May 2023

53

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Mechanism of potentiation of barbiturates and mepbrobamate actions by imipramine

4 May 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

Pharmacological Reviews

60

17

101

Klerman

1965

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Japanese journal of pharmacy and chemistry

4 May 2023

61

32

1

Kumada

1960

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Anatgonism of guanethidine by imipramine

4 May 2023

64

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

A TRIAL OF FOUR ANTI-DEPRESSANT DRUGS

4 May 2023

65

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Potentiation of the Anti-reserpine Effects of Dihydroxyphenylalanine by Antidepressants and Stimulants

4 May 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

THE METABOLISM OF NORTRIPTYLINE-N-METHYL-14C IN RATS

4 May 2023

71

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Demonstration of Anti-Depressant or Stimulant Properties of Imipramine in Experimental Animals

4 May 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

SOME ANALOGS OF IMIPRAMINE

4 May 2023

78

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Interaction between iminodibenzyl-derivatives or phenothiazine-derivatives and methamphetamine in the rat

4 May 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Interaction between iminodibenzyl-derivatives or phenothiazine-derivatives and methamphetamine in the rat

4 May 2023

80

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Effects of imipramine upon hypothalamic and amygdaloid excitability

4 May 2023

84

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Enhancement of Imipramine Mortality in Hyperthyroid Mice

4 May 2023

89

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Diminution of Imipramine Mortality in Hypothyroid Mice

4 May 2023

90

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Demethylation of imipramine in male and female rats

4 May 2023

91

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

93

6

197

Quinn

1964

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

AMITRIPTYLINE AND NORTRIPTYLINE AS ANTAGONISTS OF CENTRAL AND PERIPHERAL CHOLINERGIC ACTIVATION

4 May 2023

95

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

Pharmacological Reviews

96

11

494

Rothballer

1959

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Potentiating action of imipramine upon “reticular arousal”

4 May 2023

97

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Effects of psychotropic drugs on limbic system of cat.

4 May 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

BEHAVIORAL EFFECTS OF INTERACTING IMIPRAMINE AND OTHER DRUGS WITH D-AMPHETAMINE, COCAINE, AND TETRABENAZINE

4 May 2023

102

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

THE SURFACE ACTIVITY OF TRANQUILIZERS

4 May 2023

105

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

THE EFFECT OF DESMETHYLIMIPRAMINE ON RESERPINE AND INSULIN-INDUCED RELEASE OF GASTRIC HISTAMINE AND ADRENAL CATECHOLAMINES

4 May 2023

106

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

109

3

79

Sigg

1961

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Antagonism to reserpine induced depression by imipramine, related psychoactive drugs, and some autonomic agents

4 May 2023

111

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

An electroencephalographic study of the blocking action of selected tranquilizers as a function of terminal methyl amine group

4 May 2023

117

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

A PHARMACOLOGICAL INVESTIGATION OF POTENTIAL ANTIDEPRESSANTS OF THE AMITRIPTYLINE-TYPE.

4 May 2023

118

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

120

6

196

Sulser

1964

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

On the mechanism of antidepressant action of imipraminelike drugs

4 May 2023

123

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

135

3

60

Weissman

1961

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Clinical pharmacology of central stimulant and antidepressant drugs

4 May 2023

136

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

Differential antagonism of reserpine eyelid closure by imipramine and amphetamine.

4 May 2023

137

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

NEW PSYCHOTROPIC AGENTS. IV. DERIVATIVES OF DIBENZO(A,D)(1,4)CYCLOOECTADIENE

4 May 2023

138

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

EFFECT OF IMIPRAMINE AND SOME ANALOGUES ON THE UPTAKE OF 5-HYDROXYTRYPTAMINE BY HUMAN BLOOD PLATELETS IN VITRO

4 May 2023

139

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

[Pharmacological properties of antidepressive drugs.]

4 May 2023

140

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60137-3

4 May 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5337729

4 May 2023

1 reference